About N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine
N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine (PubChem CID 143664074) has the molecular formula C31H45BrFN7O2
and a molecular weight of 646.65 g/mol. Its IUPAC name is N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine.
Molecular Properties
| Compound Name | N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine |
| PubChem CID | 143664074 |
| Molecular Formula | C31H45BrFN7O2 |
| Molecular Weight | 646.65 g/mol |
| Exact Mass | 645.28 |
| IUPAC Name | N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine |
| SMILES | CC(=O)C(C)(C)F.CCCN1CCN(c2ccc(C)cc2)CC1.N#Cc1ncc(Br)c(N(NC=O)C2CCCCC2)n1 |
| InChI | InChI=1S/C14H22N2.C12H14BrN5O.C5H9FO/c1-3-8-15-9-11-16(12-10-15)14-6-4-13(2)5-7-14;13-10-7-15-11(6-14)17-12(10)18(16-8-19)9-4-2-1-3-5-9;1-4(7)5(2,3)6/h4-7H,3,8-12H2,1-2H3;7-9H,1-5H2,(H,16,19);1-3H3 |
| InChIKey | HBNSOVHWMBFEAF-UHFFFAOYSA-N |
| XLogP | 5.76 |
| TPSA | 105.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 42 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 646.65 |
| LogP ≤ 5 | 5.76 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'aldehyde', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Analyze N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine?
The IUPAC name of N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine (CID 143664074) is N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine.
What is the SMILES notation for N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine?
The canonical SMILES for N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine is CC(=O)C(C)(C)F.CCCN1CCN(c2ccc(C)cc2)CC1.N#Cc1ncc(Br)c(N(NC=O)C2CCCCC2)n1.
What is the InChIKey of N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine?
The InChIKey is HBNSOVHWMBFEAF-UHFFFAOYSA-N. The full InChI is InChI=1S/C14H22N2.C12H14BrN5O.C5H9FO/c1-3-8-15-9-11-16(12-10-15)14-6-4-13(2)5-7-14;13-10-7-15-11(6-14)17-12(10)18(16-8-19)9-4-2-1-3-5-9;1-4(7)5(2,3)6/h4-7H,3,8-12H2,1-2H3;7-9H,1-5H2,(H,16,19);1-3H3.
What are the key properties of N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine?
N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine has a molecular weight of 646.65 g/mol, XLogP of 5.76, 8 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(5-bromo-2-cyanopyrimidin-4-yl)-cyclohexylamino]formamide;3-fluoro-3-methylbutan-2-one;1-(4-methylphenyl)-4-propylpiperazine is sourced from PubChem (CID 143664074), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).